Τόμος 28 (2010) – Τεύχος 2 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 28 (2010) – Issue 2 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Κ. Λ. Παπαδόπουλος¹, Π. Κ. Παπαδόπουλος²

¹Ομότιμος Καθηγητής Καρδιολογίας Α.Π.Θ., Πρώην Διευθυντής Β΄ Καρδιολογικής Κλινικής, ²Δρ Ειδικός Καρδιολόγος, Άμισθος Επιστημονικός Συνεργάτης της Β΄ Καρδιολογικής Κλινικής, Αριστοτέλειο Πανεπιστήμιο, Θεσσαλονίκη, Ελλάς

C.L. Papadopoulos¹, P.C. Papadopoulos²

¹Emer. Prof. Cardiol. Aristotle Univ., Former Director, 2^nd Dept. Cardiol. Thessaloniki, Hellas
²Cardiologist, PhD Democritus Univ. Thrace, Hellas

2. Mestroni L., Gilbert E.M., Lowes B.D., Bristow M.R.: Dilated Cardiomyopathies. In: (Fuster V., Walsh R.A., O’ Rourke R.A., Poole-Wilson P., eds) Hurst’v s The Heart. Pp 803-821, Mc Giaw Hill, New York, 2008

3. Gilbert E.M., Mason J.W.: Immunosuppressive therapy of myocarditis. In: (Engelmeier R.S., O’ Connel J.B., eds) Drug Therapy in Dilated Cardiomyopathy and myocarditis. Pp. 233-263, Marcel Dekker New York, 1987

4. Cooper L.T.: The heart is off: Immunosuppression for myocarditis revisited. Eur. Heart J. 30: 1936-1939 (2009)

5. New N., Rose N.R., Beisel K.W., et al.: Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139: 3630 (1987)

6. Wolffram L.L., Beisel K.W., Rose N.R.: Heart-specific autoantibodies following murine cocsackie virus B3 myocarditis. J. Exp. Med. 161: 1112 (1985)

7. Hess O.M., McKenna W., Sohultheiss H.P., et al.: Myocardial disease. In: (Camm A.J., Lusvher T.F., Serruys P.W., eds) The ESC textbook of cardiovascular medicine. Pp. 453-516, Blackwell, Oxford, 2006

8. Rao I., Debban M., Sabbatini P., et al:: The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89: 7742-7746 (1992)

9. Liu P., Sole M.J.: What is the relevance of apoptosis to the myocardium? Cand. J. Cardiol. 15: 8B (1999)

10. Kindermann I., Kindermann M., Kandoff R., et al.: Predictors of outcome in patients with suspected myocarditis. Circulation 118: 639-648 (2008)

11. Wojnicz R., Nowalany-Kozielska E., Wojciechowska C., et al.: Randomized, placebo-controlled study for the treatment of inflammatory dilated Cardiomyopathy. Circulation 104: 39-45 (2001)

12. Kingel K.: Moleculaar biologic detection of virus infection in myocarditis and adilated cardiomyopathy. In: (Cooper L.T., ed.) Myocarditis. Pp.295-324, Humane Press, Totowa NJ, 2002

13. Kühl U., Schultheiss H.-P.: Treatment of chronic myocarditis with corticosteroids. Eur. Heart J. 16(Suppl O): 168-172 (1995)

14. Noutsias M., Seeberg B., Schultheisstt B., Kulh U.: Expression of cell adhesion molecules in dilated cardiomyopathy. Circulation 99: 2124-2131 (1999)

15. Staudt A., Schäper .F, Stangl V., Plagemann A., at al.: Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103: 2681-2686 (2001)

16. Frustaci A., Russo M.A., Chimenti C.: Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: The TIMIC study. Eur. Heart J. 30: 1995-2002 (2009)